Salibulan, Dylan .

HRN: 29-39-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2026
CEFUROXIME 750MG (VIAL)
07/29/2026
08/04/2026
IV
400mg
Q8hr
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: